GW Pharma expects fiscal 2020 sales to reach $526 million

[MJBizDaily]

United Kingdom-based GW Pharmaceuticals expects to report annual sales of approximately $526 million for the year ended Dec. 31, 2020, it said in a preview of its fourth quarter and full-year results. Fourth quarter net sales will be approximately $148 million, based on preliminary unaudited financial information, GW said in a news release this week. […]

GW Pharma expects fiscal 2020 sales to reach $526 million is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Continue reading...